| Hypothalamic neuropeptide systems as targets for potential anti-obesity drugs. | |
| | |
MedLine Citation:
|
PMID: 17266633 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Food intake and energy homeostasis are controlled by peripheral humoral signals, afferent neuronal pathways to the brain and central signals, represented, in particular, by neuropeptides. This review reports the status of development of novel compounds targeting some hypothalamic neuropeptide systems which are currently viewed as potential targets to treat obesity. |
| | |
Authors:
|
E Dozio; M Ruscica; M Motta; P Magni |
Related Documents
:
|
19456363 - Interplay of the endocannabinoid system with neuropeptide y and corticotropin-releasing... 12355323 - Acute and chronic administration of melanin-concentrating hormone enhances food intake ... 8979163 - Contributions of food groups to estimated intakes of nutritional elements: results from... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Mini reviews in medicinal chemistry Volume: 7 ISSN: 1389-5575 ISO Abbreviation: Mini Rev Med Chem Publication Date: 2007 Jan |
Date Detail:
|
Created Date: 2007-02-01 Completed Date: 2007-03-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101094212 Medline TA: Mini Rev Med Chem Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 11-9 Citation Subset: IM |
Affiliation:
|
Istituto di Endocrinologia, Universita' degli Studi di Milano, via G. Balzaretti, 9, 20133 Milano-Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Obesity Agents / pharmacology* Humans Hypothalamus / drug effects*, metabolism Neuropeptides / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Obesity Agents; 0/Neuropeptides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Currently available drugs for the treatment of obesity: Sibutramine and orlistat.
Next Document: Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approache...